Clinical Trials Directory

Trials / Terminated

TerminatedNCT02110212

Femtosecond Laser for Cataract Surgery

A Prospective, Randomized Study of Cataract Surgery With the Assistance of the OptiMedica Femtosecond Laser System Compared to Standard Surgical Procedure of Continuous Curvilinear Capsulorhexis and Ultrasonic Phacoemulsification

Status
Terminated
Phase
Phase 3
Study type
Interventional
Enrollment
17 (actual)
Sponsor
Abbott Medical Optics · Industry
Sex
All
Age
50 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The objective of this study is to evaluate the safety and efficacy the OptiMedica Femtosecond Laser System, also known as the Catalys™ Precision Laser System, to perform two surgical maneuvers used in the treatment of subjects with cataracts. Efficacy will be evaluated by comparisons to the standard surgical procedure of continuous curvilinear capsulorhexis (CCC) and ultrasonic phacoemulsification.

Conditions

Interventions

TypeNameDescription
PROCEDUREU/S Surgery and CCCSubjects will receive the standard of care for U/S cataract surgery and CCC to facilitate removal of the crystalline lens.
DEVICEFS Laser SurgeryThe Catalys System is an ophthalmic surgical laser system intended for use in cataract surgery.

Timeline

Start date
2011-04-01
Primary completion
2011-12-01
Completion
2014-02-01
First posted
2014-04-10
Last updated
2025-02-04

Source: ClinicalTrials.gov record NCT02110212. Inclusion in this directory is not an endorsement.

Femtosecond Laser for Cataract Surgery (NCT02110212) · Clinical Trials Directory